Stocks and Investing Stocks and Investing
Mon, April 11, 2022

Justin Kim Maintained (BCRX) at Buy with Decreased Target to $16 on, Apr 11th, 2022


Published on 2024-10-27 20:23:39 - WOPRAI, Justin Kim
  Print publication without navigation


Justin Kim of Oppenheimer, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy with Decreased Target from $20 to $16 on, Apr 11th, 2022.

Justin, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources